Saudi Arabia's FDA will prohibit cosmetic products in syringe form starting 1 January 2027. Ampoules and vials remain permitted conditionally if they feature four specific Arabic and English warnings on packaging. Brands have until 31 December 2026 to recall affected stock and update compliance. This regulation treats packaging format as an implied claim, requiring K-beauty brands to audit both bilingual labelling and marketing assets to avoid market restrictions.